Opus Genetics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $3,865 | $3,079 | $2,882 | $4,370 |
Gross Profit | 3,852 | 3,066 | -3,140 | 4,370 |
EBITDA | -11,440 | -17,373 | -8,892 | -6,809 |
EBIT | -11,453 | -17,386 | -8,906 | -6,822 |
Net Income | -16,523 | -17,454 | -7,420 | -8,194 |
Net Change In Cash | 3,865 | 3,079 | 2,882 | 4,370 |
Free Cash Flow | -9,833 | -6,157 | -10,269 | -8,994 |
Cash | 45,091 | 30,815 | 32,429 | 41,792 |
Basic Shares | 622,219 | 70,636 | 63,376 | 33,884 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $14,196 | $10,992 | $19,049 | $39,850 |
Gross Profit | 14,143 | 10,992 | 19,049 | 39,850 |
EBITDA | -38,599 | -57,522 | -9,968 | 18,216 |
EBIT | -38,652 | -57,532 | -9,974 | 18,212 |
Net Income | -49,591 | -57,532 | -9,986 | 17,888 |
Net Change In Cash | 14,196 | 10,992 | 19,049 | 39,850 |
Free Cash Flow | -35,253 | -25,576 | -1,112 | 14,314 |
Cash | 45,091 | 30,321 | 50,501 | 42,634 |
Basic Shares | 622,219 | 26,715 | 21,589 | 20,597 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.25 |
2025-06-30 | -$0.12 |
